Energy Expenditure, Protein Oxidation and Body Composition in a Cohort of Very Low Birth Weight Infants.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
06 Nov 2021
Historique:
received: 22 09 2021
revised: 19 10 2021
accepted: 03 11 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 21 12 2021
Statut: epublish

Résumé

The nutritional management of preterm infants is a critical point of care, especially because of the increased risk of developing extrauterine growth restriction (EUGR), which is associated with worsened health outcomes. Energy requirements in preterm infants are simply estimated, so the measurement of resting energy expenditure (REE) should be a key point in the nutritional evaluation of preterm infants. Although predictive formulae are available, it is well known that they are imprecise. The aim of our study was the evaluation of REE and protein oxidation (Ox) in very low birth weight infants (VLBWI) and the association with the mode of feeding and with body composition at term corrected age. Indirect calorimetry and body composition were performed at term corrected age in stable very low birth weight infants. Urinary nitrogen was measured in spot urine samples to calculate Ox. Infants were categorized as prevalent human milk (HMF) or prevalent formula diet (PFF). Fifty VLBWI (HMF: 23, PFF: 27) were evaluated at 36.48 ± 0.85 post-conceptional weeks. No significant differences were found in basic characteristics or nutritional intake in the groups at birth and at the assessment. No differences were found in the REE of HMF vs. PFF (59.69 ± 9.8 kcal/kg/day vs. 59.27 ± 13.15 kcal/kg/day, respectively). We found statistical differences in the protein-Ox of HMF vs. PFF (1.7 ± 0.92 g/kg/day vs. 2.8 ± 1.65 g/kg/day, respectively, REE is similar in infants with a prevalent human milk diet and in infants fed with formula. The HMF infants showed a lower oxidation rate of proteins for energy purposes and a better quality of growth. A greater amount of protein in HMF is probably used for anabolism and fat-free mass deposition. Further studies are needed to confirm our hypothesis.

Identifiants

pubmed: 34836218
pii: nu13113962
doi: 10.3390/nu13113962
pmc: PMC8620881
pii:
doi:

Substances chimiques

Dietary Proteins 0
Nitrogen N762921K75

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Arch Dis Child. 2010 Dec;95(12):1034-8
pubmed: 20371586
Pediatrics. 2015 Jul;136(1):e84-92
pubmed: 26101360
Nutrients. 2019 Aug 30;11(9):
pubmed: 31480225
Am J Clin Nutr. 2018 Feb 1;107(2):195-200
pubmed: 29529139
Arch Dis Child. 2019 Aug;104(8):725-727
pubmed: 30032114
Arch Pediatr. 2020 May;27(4):227-232
pubmed: 32278588
Acta Paediatr. 1997 May;86(5):518-22
pubmed: 9183492
J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):708-712
pubmed: 27050053
Am J Clin Nutr. 1982 May;35(5 Suppl):1169-75
pubmed: 7081099
Nutrition. 2021 Jun;86:111180
pubmed: 33676329
Pediatr Res. 2003 Mar;53(3):486-92
pubmed: 12595599
Am J Clin Nutr. 1998 Jan;67(1):74-80
pubmed: 9440378
Nutrients. 2020 Apr 26;12(5):
pubmed: 32357530
J Pediatr. 2003 Dec;143(6):750-3
pubmed: 14657822
J Transl Med. 2016 Jul 01;14(1):195
pubmed: 27370649
Eur J Pediatr. 2020 Sep;179(9):1469-1479
pubmed: 32193657
Arch Dis Child. 1982 Dec;57(12):898-904
pubmed: 6897504
Pediatr Res. 1986 Jul;20(7):638-45
pubmed: 3725461
JPEN J Parenter Enteral Nutr. 2003 Jan-Feb;27(1):21-6
pubmed: 12549594
Br J Surg. 1983 Jan;70(1):32-5
pubmed: 6402049
Antioxidants (Basel). 2018 Mar 02;7(3):
pubmed: 29498645
PLoS One. 2012;7(12):e51166
pubmed: 23227249
Nutrition. 2019 Oct;66:1-4
pubmed: 31177055
Nutrients. 2016 Oct 23;8(10):
pubmed: 27782098
Ann Surg. 1980 Jan;191(1):40-6
pubmed: 6766297
Pediatr Res. 2012 Sep;72(3):316-20
pubmed: 22669294
Pediatrics. 2018 Feb;141(2):
pubmed: 29301912
Pediatr Res. 1983 Nov;17(11):891-8
pubmed: 6646900
J Appl Physiol Respir Environ Exerc Physiol. 1983 Aug;55(2):628-34
pubmed: 6618956
J Physiol. 1949 Aug;109(1-2):1-9
pubmed: 15394301
Clin Perinatol. 2000 Mar;27(1):181-95, vii-viii
pubmed: 10690571
Environ Health. 2012 Jun 27;11:42
pubmed: 22715989
J Pediatr Gastroenterol Nutr. 2010 Jan;50(1):85-91
pubmed: 19881390
Br J Nutr. 2016 Jul;116(1):132-41
pubmed: 27181767
J Pediatr. 2016 Jun;173:108-15
pubmed: 27056450
J Nutr Biochem. 2017 Mar;41:1-11
pubmed: 27771491
J Pediatr Gastroenterol Nutr. 2017 Jan;64(1):115-118
pubmed: 27149252
J Pediatr. 1984 Jul;105(1):79-85
pubmed: 6737152
J Perinatol. 2016 Jul;36(7):500-2
pubmed: 27339826

Auteurs

Michela Perrone (M)

Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Camilla Menis (C)

Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.

Pasqua Piemontese (P)

Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Chiara Tabasso (C)

Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Domenica Mallardi (D)

Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Anna Orsi (A)

Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Orsola Amato (O)

Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Nadia Liotto (N)

Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Paola Roggero (P)

Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.

Fabio Mosca (F)

Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH